Page 214 - Effective healthcare cost containment policies Using the Netherlands as a case study - Niek W. Stadhouders
P. 214
Melnick, G. A., and Zwanziger, J. (1988). Hospital behavior under competition and cost-containment policies. The California experience, 1980 to 1985. Jama 260, 2669-75.
Melnick, G. A., and Zwanziger, J. (1995). State health care expenditures under competition and regulation, 1980 through 1991. American Journal of Public Health 85, 1391-1396.
Merrill, J., and McLaughlin, C. (1986). Competition versus regulation: some empirical evidence. J Health Polit Policy Law 10, 613-23.
Mesman, R., Faber, M. J., Berden, B. J. J. M., and Westert, G. P. (2017). Evaluation of minimum volume standards for surgery in the Netherlands (2003–2017): A successful policy? Health Policy 121, 1263-1273.
Mestre-Ferrandiz, J. (2003). Reference prices and generic medicines: What can we expect? Journal of Generic Medicines 1, 31-38.
Mikkers, M., and Ryan, P. (2014). “Managed competition” for Ireland? The single versus multiple payer debate. BMC health services research 14, 442.
Mladovsky, P., Srivastava, D., Cylus, J., Karanikolos, M., Evetovits, T., Thomson, S., and McKee, M. (2012). Health policy responses to the financial crisis in Europe.
Mobley, L. R. (1998a). Effects of selective contracting on hospital efficiency, costs and accessibility. Health economics 7, 247-261.
Mobley, L. R. (1998b). Effects of selective contracting on hospital efficiency, costs and accessibility. Health Econ 7, 247-61.
Monaco, R. M., and Phelps, J. H. (1995). Health care prices, the federal budget, and economic growth. Health Affairs 14, 248-259.
Mongan, J. J., Ferris, T. G., and Lee, T. H. (2008). Options for Slowing the Growth of Health Care Costs. New England Journal of Medicine 358, 1509-1514.
Moore, W. J., Gutermuth, K., and Pracht, E. E. (2000). Systemwide effects of Medicaid retrospective drug utilization review programs. Journal of Health Politics Policy and Law 25, 653-688.
Moreno-Serra, R. (2014). The impact of cost-containment policies on health expenditure: Evidence from recent OECD experiences. OECD Journal on Budgeting 13, 1B.
Moreno-Serra, R., and Smith, P. C. (2015). Broader health coverage is good for the nation's health: evidence from country level panel data. Journal of the Royal Statistical Society. Series A, (Statistics in Society) 178, 101-124.
Morris, L. (2009). Combating fraud in health care: an essential component of any cost containment strategy. Health Affairs 28, 1351-1356.
Mosca, I. (2007). Decentralization as a Determinant of Health Care Expenditure: Empirical Analysis for OECD Countries. Applied Economics Letters 14, 511-515.
Mosca, I., Pomp, M., and Shestalova, V. (2007). "Market Share and Price in Dutch Home Care: market power or quality?." CPB.
Moscone, F., Tosetti, E., and Vittadini, G. (2012). Social interaction in patients’ hospital choice: evidence from Italy. In "Journal of the Royal Statistical Society: Series A (Statistics in Society)", Vol. 175, pp. 453-472.
Mot, E. S., and Aouragh, A. (2010). "The Dutch system of long-term care," ENEPRI.
Mukamel, D. B., and Mushlin, A. I. (1998). Quality of care information makes a difference: an analysis of market share and price changes after publication of the New York State Cardiac Surgery Mortality
Reports. Medical care, 945-954.
Muller, A., and Baker, J. A. (1996). Evaluation of the Arkansas Medicaid primary care physician
management program. Health Care Financ Rev 17, 117-33.
Murphy, K. M., and Topel, R. H. (2003). Diminishing returns?: The costs and benefits of improving health.
Perspectives in biology and medicine 46, S108-S128.
Murray, C. J. L., and Frenk, J. (2010). Ranking 37th — Measuring the Performance of the U.S. Health Care
System. New England Journal of Medicine 362, 98-99.
Murthy, V. N., and Okunade, A. A. (2016). Determinants of US health expenditure: Evidence from
autoregressive distributed lag (ARDL) approach to cointegration. Economic Modelling 59, 67-73. NCPE (2017). "Cost-effectiveness of Nusinersen (Spinraza) for the treatment of 5q spinal muscular atrophy
(SMA).", http://www.ncpe.ie/wp-content/uploads/2017/08/Summary-Nusinersen.pdf.
NCSL (2011). "Health cost containment and efficiencies."
Neumann, P. J., Cohen, J. T., and Weinstein, M. C. (2014). Updating Cost-Effectiveness — The Curious
Resilience of the $50,000-per-QALY Threshold. New England Journal of Medicine 371, 796-797. Newhouse, J. P. (1992). Medical care costs: how much welfare loss? The Journal of Economic
Perspectives, 3-21. 206
